CA Stock MarketDetailed Quotes

BriaCell Therapeutics Corp (BCT)

Watchlist
  • 6.090
  • +0.180+3.05%
15min DelayMarket Closed Apr 17 16:00 ET
44.16MMarket Cap-0.31P/E (TTM)

BriaCell Therapeutics Corp (BCT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jan 31, 2026
(Q1)Oct 31, 2025
(FY)Jul 31, 2025
(Q4)Jul 31, 2025
(Q3)Apr 30, 2025
(Q2)Jan 31, 2025
(Q1)Oct 31, 2024
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
5.05%7.53M
61.52%8.32M
-18.38%27.2M
48.31%8.55M
-31.44%6.33M
-27.06%7.17M
-39.40%5.15M
43.22%33.33M
-25.15%5.77M
62.58%9.23M
Selling and administrative expenses
-0.48%1.48M
10.21%1.64M
-3.55%5.93M
5.98%1.44M
-3.43%1.52M
-5.56%1.48M
-9.62%1.49M
-22.47%6.15M
-46.32%1.36M
-13.46%1.57M
-General and administrative expense
-0.48%1.48M
10.21%1.64M
-3.55%5.93M
5.98%1.44M
-3.43%1.52M
-5.56%1.48M
-9.62%1.49M
-22.47%6.15M
-46.32%1.36M
-13.46%1.57M
Research and development costs
6.49%6.05M
82.35%6.68M
-21.74%21.27M
61.40%7.11M
-37.18%4.81M
-31.16%5.68M
-46.55%3.67M
77.21%27.18M
-14.75%4.41M
98.36%7.66M
Operating profit
-5.05%-7.53M
-61.52%-8.32M
18.38%-27.2M
-48.31%-8.55M
31.44%-6.33M
27.06%-7.17M
39.40%-5.15M
-43.22%-33.33M
25.15%-5.77M
-62.58%-9.23M
Net non-operating interest income (expenses)
125.57%105.64K
271.51%48.48K
-71.19%82.98K
1,672,100.00%33.44K
-166.30%-10.35K
-42.60%46.83K
-93.16%13.05K
-67.68%288.02K
-100.00%2
-93.84%15.61K
Non-operating interest income
125.57%105.64K
271.51%48.48K
-58.35%119.96K
1,672,100.00%33.44K
70.65%26.63K
-42.60%46.83K
-93.16%13.05K
-67.68%288.02K
-100.00%2
-93.84%15.61K
Non-operating interest expense
----
----
--36.98K
--0
--36.98K
----
----
--0
--0
--0
Other net income (expenses)
-83.60%128.74K
99.44%-3.87K
-97.99%565.68K
-92.11%356.72K
-98.96%113.67K
149.48%784.78K
-104.83%-689.49K
1,252.34%28.11M
-11.01%4.52M
1,965.18%10.91M
Gain on sale of security
-76.95%190.73K
106.63%40.96K
-97.20%789.9K
-91.16%404.1K
-98.39%176.41K
152.78%827.37K
-104.33%-617.98K
1,257.46%28.22M
-10.00%4.57M
1,972.18%10.94M
Income before tax
-15.13%-7.3M
-42.01%-8.28M
-438.50%-26.56M
-553.78%-8.16M
-467.85%-6.22M
44.08%-6.34M
-197.83%-5.83M
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
Income tax
Earnings from equity interest net of tax
Net income
-15.13%-7.3M
-42.01%-8.28M
-438.50%-26.56M
-553.78%-8.16M
-467.85%-6.22M
44.08%-6.34M
-197.83%-5.83M
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
Net income continuous operations
-15.13%-7.3M
-42.01%-8.28M
-438.50%-26.56M
-553.78%-8.16M
-467.85%-6.22M
44.08%-6.34M
-197.83%-5.83M
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
Noncontrolling interests
-61.77%-75.07K
-198.01%-80.76K
-74.38%-244.27K
-110.30%-72.74K
-316.83%-98.03K
-18.07%-46.41K
36.49%-27.1K
-140.08K
-34.59K
-23.52K
Net income attributable to the company
-14.79%-7.22M
-41.28%-8.2M
-449.14%-26.31M
-566.41%-8.09M
-457.10%-6.13M
44.30%-6.29M
-196.68%-5.8M
76.40%-4.79M
49.80%-1.21M
135.05%1.72M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-14.79%-7.22M
-41.28%-8.2M
-449.14%-26.31M
-566.41%-8.09M
-457.10%-6.13M
44.30%-6.29M
-196.68%-5.8M
76.40%-4.79M
49.80%-1.21M
135.05%1.72M
Diluted earnings per share
88.93%-2.58
86.69%-4.35
-42.38%-62.19
57.39%-4.295
-201.86%-16.4
78.09%-23.31
-157.32%-32.67
77.60%-43.68
55.20%-10.08
133.54%16.1
Basic earnings per share
88.93%-2.58
86.69%-4.35
-42.38%-62.19
57.39%-4.295
-201.86%-16.4
78.09%-23.31
56.44%-32.67
77.60%-43.68
55.20%-10.08
133.54%16.1
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jan 31, 2026(Q1)Oct 31, 2025(FY)Jul 31, 2025(Q4)Jul 31, 2025(Q3)Apr 30, 2025(Q2)Jan 31, 2025(Q1)Oct 31, 2024(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 5.05%7.53M61.52%8.32M-18.38%27.2M48.31%8.55M-31.44%6.33M-27.06%7.17M-39.40%5.15M43.22%33.33M-25.15%5.77M62.58%9.23M
Selling and administrative expenses -0.48%1.48M10.21%1.64M-3.55%5.93M5.98%1.44M-3.43%1.52M-5.56%1.48M-9.62%1.49M-22.47%6.15M-46.32%1.36M-13.46%1.57M
-General and administrative expense -0.48%1.48M10.21%1.64M-3.55%5.93M5.98%1.44M-3.43%1.52M-5.56%1.48M-9.62%1.49M-22.47%6.15M-46.32%1.36M-13.46%1.57M
Research and development costs 6.49%6.05M82.35%6.68M-21.74%21.27M61.40%7.11M-37.18%4.81M-31.16%5.68M-46.55%3.67M77.21%27.18M-14.75%4.41M98.36%7.66M
Operating profit -5.05%-7.53M-61.52%-8.32M18.38%-27.2M-48.31%-8.55M31.44%-6.33M27.06%-7.17M39.40%-5.15M-43.22%-33.33M25.15%-5.77M-62.58%-9.23M
Net non-operating interest income (expenses) 125.57%105.64K271.51%48.48K-71.19%82.98K1,672,100.00%33.44K-166.30%-10.35K-42.60%46.83K-93.16%13.05K-67.68%288.02K-100.00%2-93.84%15.61K
Non-operating interest income 125.57%105.64K271.51%48.48K-58.35%119.96K1,672,100.00%33.44K70.65%26.63K-42.60%46.83K-93.16%13.05K-67.68%288.02K-100.00%2-93.84%15.61K
Non-operating interest expense ----------36.98K--0--36.98K----------0--0--0
Other net income (expenses) -83.60%128.74K99.44%-3.87K-97.99%565.68K-92.11%356.72K-98.96%113.67K149.48%784.78K-104.83%-689.49K1,252.34%28.11M-11.01%4.52M1,965.18%10.91M
Gain on sale of security -76.95%190.73K106.63%40.96K-97.20%789.9K-91.16%404.1K-98.39%176.41K152.78%827.37K-104.33%-617.98K1,257.46%28.22M-10.00%4.57M1,972.18%10.94M
Income before tax -15.13%-7.3M-42.01%-8.28M-438.50%-26.56M-553.78%-8.16M-467.85%-6.22M44.08%-6.34M-197.83%-5.83M75.71%-4.93M48.37%-1.25M134.57%1.69M
Income tax
Earnings from equity interest net of tax
Net income -15.13%-7.3M-42.01%-8.28M-438.50%-26.56M-553.78%-8.16M-467.85%-6.22M44.08%-6.34M-197.83%-5.83M75.71%-4.93M48.37%-1.25M134.57%1.69M
Net income continuous operations -15.13%-7.3M-42.01%-8.28M-438.50%-26.56M-553.78%-8.16M-467.85%-6.22M44.08%-6.34M-197.83%-5.83M75.71%-4.93M48.37%-1.25M134.57%1.69M
Noncontrolling interests -61.77%-75.07K-198.01%-80.76K-74.38%-244.27K-110.30%-72.74K-316.83%-98.03K-18.07%-46.41K36.49%-27.1K-140.08K-34.59K-23.52K
Net income attributable to the company -14.79%-7.22M-41.28%-8.2M-449.14%-26.31M-566.41%-8.09M-457.10%-6.13M44.30%-6.29M-196.68%-5.8M76.40%-4.79M49.80%-1.21M135.05%1.72M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -14.79%-7.22M-41.28%-8.2M-449.14%-26.31M-566.41%-8.09M-457.10%-6.13M44.30%-6.29M-196.68%-5.8M76.40%-4.79M49.80%-1.21M135.05%1.72M
Diluted earnings per share 88.93%-2.5886.69%-4.35-42.38%-62.1957.39%-4.295-201.86%-16.478.09%-23.31-157.32%-32.6777.60%-43.6855.20%-10.08133.54%16.1
Basic earnings per share 88.93%-2.5886.69%-4.35-42.38%-62.1957.39%-4.295-201.86%-16.478.09%-23.3156.44%-32.6777.60%-43.6855.20%-10.08133.54%16.1
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More